| [1] |
Gile J,Eckle T. ADORA2b Signaling in Cardioprotection[J]. J Nat Sci, 2016, 2(10). pii: e222.
|
| [2] |
Gao ZW,Wang HP,Fang L, et al. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity[J]. BMC Cancer, 2017, 17(1):135.
|
| [3] |
Allard B,Turcotte M,Stagg J. CD73-Generated adenosine: orchestrating the Tumor-Stroma interplay to promote cancer growth[J]. J Biomed Biotechnol, 2012, 16(10):485156.
|
| [4] |
Sciarra A,Monteiro I,Ménétrier-Caux C, et al. Correction to:CD73 expression in normal and pathological human hepatobiliopancreatic tissues[J]. Cancer Immunol Immunother, 2019, 68(3):529.
|
| [5] |
Sek K,Mølck C,Stewart GD, et al. Targeting adenosine receptor signaling in cancer immunotherapy[J]. Int J Mol Sci, 2018, 19(12). pii: E3837.
|
| [6] |
Beavis PA,Stagg J,Darcy PK, et al. CD73:a potent suppressor of antitumor immune responses[J]. Trends Immunol, 2012, 33(5):231-237.
|
| [7] |
Whiteside TL,Mandapathil M,Schuler P. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg)[J]. Curr Med Chem, 2011, 18(34):5217-5223.
|
| [8] |
Young A,Ngiow SF,Barkauskas DS, et al. Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses[J]. Cancer Cell, 2016, 30(3):391-403.
|
| [9] |
Wang L,Tang S,Wang Y, et al. Ecto-5-nucleotidase (CD73) promotes tumor growth angiogenesis[J]. Clin Exp Metastasis, 2013, 30(5):671-680.
|
| [10] |
Allard B,Turcotte M,Stagg J. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer[J]. Expert Opin Ther Targets, 2014, 18(8):863-881.
|
| [11] |
Giordano G,Febbraro A,Tomaselli E, et al. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer[J]. J Exp Clin Cancer Res, 2015, 34(1):108.
|
| [12] |
Zhi X,Wang Y,Yu J, et al. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer[J]. IUBMB Life, 2012, 64(11):911-920.
|
| [13] |
Xie MH,Qin HB,Luo QX, et al. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73[J]. BMC Cancer, 2017, 17(1):305.
|
| [14] |
Yegutkin GG,Marttila-Ichihara F,Karikoski M, et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression[J]. Eur J Immunol, 2011, 41(5):1231-1241.
|
| [15] |
Sadej R,Skladanowski AC. Dual, enzymatic and non-enzymatic, function of ecto-5'-nucleotidase (eN, CD73) in migration and invasion of A375 melanoma cells[J]. Acta Biochim Pol, 2012, 59(4):647-652.
|
| [16] |
Wang H,Lee S,Lo Nigro C, et al. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity[J]. Br J Cancer, 2012, 106(8):1446-1452.
|
| [17] |
Bonner BF,Rg N,Jacoby C, et al. Ecto-5'-Nucleotidase on immune cells protects from adverse cardiac remodeling[J]. Circ Res, 2013, 113(3):301-312.
|
| [18] |
Quast C,Alter C,Ding ZP, et al. Adenosine formed by CD73 on T cells inhibits cardiac inflammation and fibrosis and preserves contractile function in transverse aortic Constriction-Induced heart failure[J]. Circ Heart Fail, 2017, 10(4):e003346.
|
| [19] |
Del Ry S,Giannessi D,Maltinti MA, et al. Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy[J]. Cytokine, 2010, 49(3):325-330.
|
| [20] |
Hensel F,Hermann R,Brändlein S, et al. Regulation of the new coexpressed CD55(decay-accelerating factor)receptor on stomach carcinoma cells involved in antibody SC-1-induced apoptosis[J]. Lab Invest, 2001, 81(11):1553-1563.
|
| [21] |
Hermes M,Osswald H,Kloor D. Adenosine metabolism and its effect on methylation potential in cultured cells: Methodological considerations[J]. Cell Mol Biol, 2006, 52(S):874-881.
|
| [22] |
Lappas CM,Rieger JM,Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells[J]. J Immunol, 2005, 174(2):1073-1080.
|
| [23] |
汪咏梅,向伟,圣蒂·莫尔. CD73对弓形虫侵入宿主细胞及其在细胞内繁殖过程的影响(英文)[J]. 临床儿科杂志, 2010, 28(8):701-709.
|
| [24] |
Bours MJ,Swennen EL,Di Virgilio F, et al. PCAdenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation[J]. Pharmacol Ther, 2006, 112(2):358-404.
|
| [25] |
Mills JH,Thompson LF,Mueller C, et al. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis[J]. 2008, 105(27):9325-9330.
|
| [26] |
Alam MS,Kurtz CC,Rowlett RM, et al. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and helicobacter felis-Induced gastritis in mice[J]. J Infect Dis, 2009, 199(4):494-504.
|
| [27] |
Karhausen J,Haase VH,Colgan SP. Inflammatory hypoxia: role of hypoxia-inducible factor[J]. Cell Cycle, 2005, 4(2):256-258.
|
| [28] |
Frantz S,Vincent KA,Feron O, et al. Innate immunity and angiogenesis [J]. Circ Res, 2005, 96(1):15-26.
|
| [29] |
Tsutsui S,Schnermann J,Noorbakhsh F, et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis[J]. J Neurosci, 2004, 24(6):1521-1529.
|
| [30] |
Lee JY,Jhun BS,Oh YT, et al. Activation of adenosine A(3) receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappa B activation in murine BV2 microglial cells[J]. Neurosci Lett, 2006, 396(1):1-6.
|
| [31] |
Mahamed DA,Mills JH,Egan CE, et al. CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system[J]. Proc Natl Acad Sci U S A, 2012, 109(40):16312-16317.
|
| [32] |
Crikis S,Lu B,Murray-Segal LM, et al. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury[J]. Am J Transplant, 2010, 10(12):2586-2595.
|
| [33] |
Ohtsuka T,Changelian PS,Bouis D, et al. Ecto-5'-Nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation[J]. J Immunol, 2010, 185(2):1321-1329.
|
| [34] |
Tak E,Jung DH,Kim SH, et al. Protective role of hypoxia-inducible factor-1 alpha-dependent CD39 and CD73 in fulminant acute liver failure[J]. Toxicol Appl Pharmacol, 2017, 314(5):72-81.
|
| [35] |
Guzman-Flores JM,Cortez-Espinosa N,Cortés-Garcia JD, et al. Expression of CD73 and a2a receptors in cells from subjects with obesity and type 2 diabetes mellitus[J]. Immunobiology, 2015, 220(8): 976-984.
|
| [36] |
Eberle D,Schubert S,Postel K, et al. Increased integration of transplanted CD73-Positive photoreceptor precursors into adult mouse retina[J]. Invest Ophthalmol Vis Sci, 2011, 52(9):6462-6471.
|
| [37] |
Wang LY,Li JH,Zhou X, et al. Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma[J]. Onco Targets Ther, 2017, 10(22):5585-5589.
|
| [38] |
Della Latta V,Cabiati M,Rocchiccioli S, et al. The role of the adenosinergic system in lung fibrosis[J]. Pharmacol Res, 2013, 76(10):182-189.
|